Three-dimensional in vivo imaging of tumors expressing red fluorescent proteins
Methods in Molecular Biology, ISSN: 1064-3745, Vol: 872, Page: 97-114
2012
- 2Citations
- 10Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
3D imaging of genetically-engineered fluorescent tumors enables quantitative monitoring of tumor growth/regression, metastatic processes, including during anticancer therapy in real-time. Fluorescent tumor models for 3D imaging require stable expression of genetically encoded fluorescent proteins and maintenance of the properties of tumor cell line including growth rate, morphology, and immunophenotype. In this chapter, the protocol for 3D imaging of tumors expressing red fluorescent protein are described in detail. © 2012 Springer Science+Business Media New York.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84867600455&origin=inward; http://dx.doi.org/10.1007/978-1-61779-797-2_7; http://www.ncbi.nlm.nih.gov/pubmed/22700406; http://link.springer.com/10.1007/978-1-61779-797-2_7; https://dx.doi.org/10.1007/978-1-61779-797-2_7; https://link.springer.com/protocol/10.1007/978-1-61779-797-2_7; http://www.springerlink.com/index/10.1007/978-1-61779-797-2_7; http://www.springerlink.com/index/pdf/10.1007/978-1-61779-797-2_7
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know